Researchphilia Daily

HVALABS
  • 0.0 (0)
  • Life Sciences
  • Daily

The research that's shaping medicine before anyone else is talking about it. Researchphilia Daily delivers a 10-minute briefing on the newest peer-reviewed studies, every single day. Built for clinicians, researchers, and anyone who wants to stay genuinely up to date. Every study we cover is in the Researchphilia app, available on the App Store, with the full abstract and a plain language summary. Save the ones you like and listen to new episodes right inside the app.

  1. Oct 24

    Adult ADHD, RSV Prevention, CAR-T's Short Win, and Fatty Liver Hormones

    Today we cover a New England Journal of Medicine review on adult ADHD, real world data on RSV vaccines and antibodies, why the first solid tumor CAR-T therapy only adds a few months of survival, a new hormonal framework for fatty liver disease, the uneven landscape of asthma biologics, and a sports nutrition society's position on weight loss diets. Plus a quick rundown of four more studies spanning exercise physiology, dermatology, oncology, and prostate cancer biology.

  2. Oct 23

    Chemo-Free Leukemia Wins, a Cardiology Puzzle, and New Options for Knee Arthritis

    A chemotherapy free regimen beats standard treatment in a major leukemia trial, and a closely watched heart disease drug lowers a key risk marker without lowering heart attacks or strokes. We also cover emerging treatments for knee osteoarthritis, a possible early step toward type two diabetes in obesity, basic science on how pancreatic cancer gets started, and a broad look at modern pain research.

  3. Oct 22

    Continuous Dialysis Wins, a Leukemia Breakthrough, and Cannabis for Sleep

    A daily briefing on new medical research for busy clinicians. Today we cover a stopped-early critical care trial on kidney support, a practice-changing leukemia regimen, a New England Journal of Medicine primer on adult ADHD, a landmark feat in computational protein design, a genetics clue linking interleukin six to heart risk in clonal hematopoiesis, and what the evidence really shows about medical cannabis for insomnia. A short rundown covers CAR T cell therapy, sports nutrition guidance, frailty exercise research, and cartilage regeneration science.

  4. Oct 21

    Chemo-Free Leukemia Wins, Estrogen's Role in Drug Resistance, and Rethinking Heart Attack Triage

    Today's briefing covers a chemotherapy-free regimen that outperforms standard treatment in Philadelphia-positive acute lymphoblastic leukemia, a Cell study showing estrogen drives resistance to antibody-drug conjugates in cancer, and new Cochrane evidence questioning medical cannabis for insomnia. We also look at a smarter way to catch blocked coronary arteries missed by standard ECG criteria, a major review of adult attention deficit hyperactivity disorder, and the shifting treatment landscape for knee osteoarthritis. A quick rundown covers bladder cancer, kidney injury, diet science, obesity drugs, and more.

  5. Oct 20

    A Leukemia Breakthrough, Gut Bacteria, and Adult ADHD

    A chemotherapy free combination beats standard treatment for adult Philadelphia positive leukemia in a major trial. New research in Nature and Cell reveals how gut bacteria and a little known gene protect arteries from plaque buildup. Plus, why vaccines cause fever in some people and not others, a practical update on adult ADHD, and a cautionary look at antibiotics in premature infants.

  6. Oct 19

    ADHD in Adults, Chemo-Free Leukemia Care, and an Oral Pill for Colitis

    Monday's briefing covers a major review on adult attention deficit hyperactivity disorder, a practice-changing leukemia trial pairing ponatinib with blinatumomab, and a phase two trial of oral icotrokinra for ulcerative colitis. We also look at the heart-liver connection, new tinnitus guidelines, and a sobering national survey on teen anxiety, plus a quick rundown of other notable papers.

  7. Oct 18

    GLP-1 and Psychiatric Risk, Liver-Heart Links, and a New Hepatitis B Pill

    Today we cover a large cohort study linking GLP-1 receptor agonists to fewer psychiatric crises in people with schizophrenia and diabetes, a Circulation review on how liver disease affects the heart, and early trial results for a new hepatitis B drug. We also look at adult ADHD, a national survey showing one in six American teens has moderate or severe anxiety, and a global policy roadmap for osteoarthritis. A quick rundown covers several more studies in immunology, sports nutrition, and joint disease.

  8. Oct 17

    ADHD, Liver-Heart Risks, New Cholesterol Pill, Teen Anxiety Data

    Today's episode looks at six new studies: a New England Journal of Medicine review on adult ADHD, a Circulation deep dive into liver disease and cardiovascular risk, a JAMA Pediatrics survey on teen anxiety, a meta-analysis of the oral cholesterol drug enlicitide, updated tinnitus treatment guidelines, and new data linking biological aging to combined heart, kidney, and metabolic decline. We also run through seven more studies in oncology, neurology, and dermatology.

See All (43)

About

The research that's shaping medicine before anyone else is talking about it. Researchphilia Daily delivers a 10-minute briefing on the newest peer-reviewed studies, every single day. Built for clinicians, researchers, and anyone who wants to stay genuinely up to date. Every study we cover is in the Researchphilia app, available on the App Store, with the full abstract and a plain language summary. Save the ones you like and listen to new episodes right inside the app.

Information